ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist in Computational Biology at Eikon Therapeutics - ApplyBlast

Scientist in Computational Biology

Eikon Therapeutics

1 month ago

3.3 on Glassdoor

Millbrae, California, United States

Onsite

Full Time

Senior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

Eikon Therapeutics is seeking a Scientist in Computational Biology to drive early drug discovery efforts by analyzing high-dimensional data, including bulk and single-cell transcriptomic datasets. The role involves collaborating with discovery scientists to design and evaluate complex experiments, building internal computational tools, and overseeing external analysis efforts. This position requires a rigorous, results-driven expert capable of resolving nuanced scientific questions through advanced data analysis and pipeline development.

Responsibilities

Analyze high-dimensional transcriptomic and genomic datasets
Build and maintain computational pipelines and workflows
Collaborate with discovery scientists to design and evaluate experiments

Skills

Qualifications

PhD in bioinformatics, computational biology, or a related quantitative field

About Eikon Therapeutics

eikontx.com

Headquarters

Millbrae, California, United States

Company Size

201-500 employees

Founded

2019

View Profile

Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.